EDARBYCLOR 40 MG
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 40 MG CHLORTHALIDONE : 25 MG · DIN 02397765 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is EDARBYCLOR?
EDARBYCLOR 40 MG contains AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 40 MG CHLORTHALIDONE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02397765, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 13-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EDARBYCLOR used for?
Initial therapy in patients with severe essential hypertension for whom the benefit of a prompt blood pressure reduction exceeds the risk of initiating combination therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02397765 |
|---|---|
| Brand name | EDARBYCLOR |
| Generic / active ingredient | AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 40 MG CHLORTHALIDONE : 25 MG |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 40 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS |
| AHFS class | 40:28.24 ; 24:32.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 13-Jul-2021 |
| Original market date | 2013-03-21 00:00:00 |
How is it administered?
Usual starting dose: 40 mg/12.5 mg once daily. May increase after 2-4 weeks. Maximally effective dose: 40 mg/25 mg once daily. Take with or without food. Do not exceed one tablet daily.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text (standard reference to section 11), but usually 15-30°C. (Note: Text ends before section 11).
How is it supplied?
40/12.5 mg: Blisters of 7 or 14 tablets. 80/12.5 mg and 40/25 mg: Blisters of 14 tablets. Supplied in cartons.
Contraindications
Hypersensitivity to components or sulfonamides; anuria; refractory hyponatremia; co-administration with aliskiren in patients with diabetes or renal impairment; pregnancy; nursing women.
Warnings and precautions
Fetal toxicity (Boxed Warning); symptomatic hypotension in volume/salt-depleted patients; renal function changes; electrolyte imbalances; angioedema; rhabdomyolysis; acute myopia/glaucoma.
What can be used instead?
Other Canadian products sharing ATC code C09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EDARBYCLOR | 12.5 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02397749 |
| EDARBYCLOR | 12.5 MG | TABLET | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 02397757 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.